5:12 PM
 | 
May 07, 2010
 |  BC Extra  |  Clinical News

Cytori reports pilot data for ADRCs

Cytori Therapeutics Inc. (NASDAQ:CYTX; Xetra:XMPA) reported data from two pilot trials of its adipose-derived regenerative cells (ADRCs) in cardiovascular indications. In the PRECISE trial to treat chronic myocardial ischemia, ADRCs injected directly into the ischemic regions of the heart significantly improved maximum...

Read the full 192 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >